370 related articles for article (PubMed ID: 25970097)
1. Mechanistic insights into a novel chromone-appended Cu(II) anticancer drug entity: in vitro binding profile with DNA/RNA substrates and cytotoxic activity against MCF-7 and HepG2 cancer cells.
Yousuf I; Arjmand F; Tabassum S; Toupet L; Khan RA; Siddiqui MA
Dalton Trans; 2015 Jun; 44(22):10330-42. PubMed ID: 25970097
[TBL] [Abstract][Full Text] [Related]
2. Structure elucidation {spectroscopic, single crystal X-ray diffraction and computational DFT studies} of new tailored benzenesulfonamide derived Schiff base copper(II) intercalating complexes: Comprehensive biological profile {DNA binding, pBR322 DNA cleavage, Topo I inhibition and cytotoxic activity}.
Afsan Z; Roisnel T; Tabassum S; Arjmand F
Bioorg Chem; 2020 Jan; 94():103427. PubMed ID: 31735357
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and antitumor mechanisms of a copper(II) complex of anthracene-9-imidazoline hydrazone (9-AIH).
Qin QP; Liu YC; Wang HL; Qin JL; Cheng FJ; Tang SF; Liang H
Metallomics; 2015 Jul; 7(7):1124-36. PubMed ID: 25904543
[TBL] [Abstract][Full Text] [Related]
4. Copper (II)-based halogen-substituted chromone antitumor drug entities: Studying biomolecular interactions with ct-DNA mediated by sigma hole formation and cytotoxicity activity.
Arjmand F; Khursheed S; Roisnel T; Siddique HR
Bioorg Chem; 2020 Nov; 104():104327. PubMed ID: 33142405
[TBL] [Abstract][Full Text] [Related]
5. Thiosemicarbazone Cu(II) and Zn(II) complexes as potential anticancer agents: syntheses, crystal structure, DNA cleavage, cytotoxicity and apoptosis induction activity.
Shao J; Ma ZY; Li A; Liu YH; Xie CZ; Qiang ZY; Xu JY
J Inorg Biochem; 2014 Jul; 136():13-23. PubMed ID: 24690556
[TBL] [Abstract][Full Text] [Related]
6. Synthesis, crystal structure and antiproliferative activity of Cu(II) nalidixic acid-DACH conjugate: comparative in vitro DNA/RNA binding profile, cleavage activity and molecular docking studies.
Arjmand F; Yousuf I; Hadda Tb; Toupet L
Eur J Med Chem; 2014 Jun; 81():76-88. PubMed ID: 24826817
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of novel coumarin nucleus-based DPA drug-like molecular entity: In vitro DNA/Cu(II) binding, DNA cleavage and pro-oxidant mechanism for anticancer action.
Khan S; Malla AM; Zafar A; Naseem I
PLoS One; 2017; 12(8):e0181783. PubMed ID: 28763458
[TBL] [Abstract][Full Text] [Related]
8. A mononuclear Cu(II) complex with 5,6-diphenyl-3-(2-pyridyl)-1,2,4-triazine: Synthesis, crystal structure, DNA- and BSA-binding, molecular modeling, and anticancer activity against MCF-7, A-549, and HT-29 cell lines.
Anjomshoa M; Hadadzadeh H; Torkzadeh-Mahani M; Fatemi SJ; Adeli-Sardou M; Rudbari HA; Nardo VM
Eur J Med Chem; 2015; 96():66-82. PubMed ID: 25874332
[TBL] [Abstract][Full Text] [Related]
9. Water soluble transition metal [Ni(II), Cu(II) and Zn(II)] complexes of
Khursheed S; Siddique HR; Tabassum S; Arjmand F
Dalton Trans; 2022 Aug; 51(31):11713-11729. PubMed ID: 35852297
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, molecular structure, biological properties and molecular docking studies on Mn(II), Co(II) and Zn(II) complexes containing bipyridine-azide ligands.
Thamilarasan V; Jayamani A; Sengottuvelan N
Eur J Med Chem; 2015 Jan; 89():266-78. PubMed ID: 25462243
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and structure elucidation of new μ-oxamido-bridged dicopper(II) complex with in vitro anticancer activity: A combined study from experiment verification and docking calculation on DNA/protein-binding property.
Zhu L; Zheng K; Li YT; Wu ZY; Yan CW
J Photochem Photobiol B; 2016 Feb; 155():86-97. PubMed ID: 26773872
[TBL] [Abstract][Full Text] [Related]
12. Design and synthesis of enantiomeric (R)- and (S)-copper(II) and diorganotin(IV)-based antitumor agents: their in vitro DNA binding profile, cleavage efficiency and cytotoxicity studies.
Arjmand F; Muddassir M; Yousuf I
J Photochem Photobiol B; 2014 Jul; 136():62-71. PubMed ID: 24857791
[TBL] [Abstract][Full Text] [Related]
13. Enantiomeric specificity of biologically significant Cu(II) and Zn(II) chromone complexes towards DNA.
Arjmand F; Jamsheera A; Afzal M; Tabassum S
Chirality; 2012 Dec; 24(12):977-86. PubMed ID: 23001645
[TBL] [Abstract][Full Text] [Related]
14. Enantiomeric fluoro-substituted benzothiazole Schiff base-valine Cu(II)/Zn(II) complexes as chemotherapeutic agents: DNA binding profile, cleavage activity, MTT assay and cell imaging studies.
Alizadeh R; Yousuf I; Afzal M; Srivastav S; Srikrishna S; Arjmand F
J Photochem Photobiol B; 2015 Feb; 143():61-73. PubMed ID: 25600265
[TBL] [Abstract][Full Text] [Related]
15. Mixed ligand μ-phenoxo-bridged dinuclear copper(II) complexes with diimine co-ligands: efficient chemical nuclease and protease activities and cytotoxicity.
Loganathan R; Ramakrishnan S; Suresh E; Palaniandavar M; Riyasdeen A; Akbarsha MA
Dalton Trans; 2014 Apr; 43(16):6177-94. PubMed ID: 24595529
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and characterization of Cu(II)-based anticancer chemotherapeutic agent targeting topoisomerase Iα: in vitro DNA binding, pBR322 cleavage, molecular docking studies and cytotoxicity against human cancer cell lines.
Tabassum S; Zaki M; Afzal M; Arjmand F
Eur J Med Chem; 2014 Mar; 74():509-23. PubMed ID: 24508781
[TBL] [Abstract][Full Text] [Related]
17. Synthesis, DNA interaction and anticancer activity of copper(II) complexes with 4'-phenyl-2,2':6',2″-terpyridine derivatives.
Liang JW; Wang Y; Du KJ; Li GY; Guan RL; Ji LN; Chao H
J Inorg Biochem; 2014 Dec; 141():17-27. PubMed ID: 25172994
[TBL] [Abstract][Full Text] [Related]
18. Enantiopure copper(II) complex of natural product rosin derivative: DNA binding, DNA cleavage and cytotoxicity.
Fei BL; Yin B; Li DD; Xu WS; Lu Y
J Biol Inorg Chem; 2016 Dec; 21(8):987-996. PubMed ID: 27628182
[TBL] [Abstract][Full Text] [Related]
19. In vitro DNA and BSA-binding, cell imaging and anticancer activity against human carcinoma cell lines of mixed ligand copper(II) complexes.
Anjomshoa M; Torkzadeh-Mahani M
Spectrochim Acta A Mol Biomol Spectrosc; 2015; 150():390-402. PubMed ID: 26057093
[TBL] [Abstract][Full Text] [Related]
20. Structure and biological properties of mixed-ligand Cu(II) Schiff base complexes as potential anticancer agents.
Gou Y; Li J; Fan B; Xu B; Zhou M; Yang F
Eur J Med Chem; 2017 Jul; 134():207-217. PubMed ID: 28415010
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
